Morphine Sulfate Injection · #6 of 35 active shortages by FDA posting duration
Brand: MORPHINE SULFATE
FDA lists Morphine Sulfate Injection as Active Shortage (Hospira, Inc., a Pfizer Company).
Availability on file: Limited Availability
Morphine Sulfate Injection: Active Shortage
Limited Availability 27 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Morphine Sulfate Injection
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Dosage Form
- Injection
- Presentation
- Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12)
- Package NDC
- 0409-3815-12
Status & Timeline
- Status
- Active Shortage
- Availability
- Limited Availability
- First Reported
- Oct 31, 2017
- Last Updated
- Mar 13, 2026
- Therapeutic Category
- Analgesia/Addiction
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Limited Supply Available. Next Delivery: June 2026; Estimated Recovery: June 2027; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay
Full Drug Profile
morphine
Side effects, interactions, warnings & more
Nearby, Other Morphine Shortage Records
Morphine Sulfate Injection
Piramal Critical Care Inc.
Injection
Morphine Sulfate Injection
Piramal Critical Care Inc.
Injection
Morphine Sulfate Injection
Fresenius Kabi USA, LLC
Injection
Morphine Sulfate Injection
Fresenius Kabi USA, LLC
Injection
Morphine Sulfate Injection
Hospira, Inc., a Pfizer Company
Injection
Morphine Sulfate Injection
Hospira, Inc., a Pfizer Company
Injection
FDA reason on file: Limited Supply Available. General shortage guidance lives on the tracker hub.